Acute myeloid leukemia: open trials in Lithuania

• NCT07223814

  Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  Trial Treatment · Phase 3 · Stichting Hemato-Oncologie voor Volwassenen Nederland

  Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius

  Registry updated 2026-11-06

• NCT04628026

  Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

  Trial Treatment · Phase 3 · University of Ulm

  Vilnius University Hospital Santaros Klinik, Vilnius

  Registry updated 2026-11-03

• NCT06459024

  Master Framework For Relapse or Refractory Acute Myeloid Leukemia

  Research · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

  The Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas

  Registry updated 2026-10-27

• NCT06713837

  IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

  Trial Treatment · Phase 3 · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

  Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos, Kaunas

  Registry updated 2026-10-27

• 2024-512753-24-00

  A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia (AML) with a specific gene abnormality who have not previously been treated and who are not eligible for intensive chemotherapy.

  Trial Treatment · Phase 3 · Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

  Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius

  Registry updated 2026-10-21

• NCT07211958

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Trial Treatment · Phase 3 · Syndax Pharmaceuticals

  Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos, Kaunas · Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius

  Registry updated 2026-10-21

• NCT05735704

  Early Detection and Screening of Hematological Malignancies - SANGUINE

  Research · JaxBio Ltd

  Vilnus University Hospital Santaros Klinikos (VULSK), Vilnius

  Registry updated 2026-10-15

• NCT04065399

  A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  Trial Treatment · Phase 1/2 · Syndax Pharmaceuticals

  Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius

  Registry updated 2026-10-09

• 2023-504999-25-00

  CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)

  Trial Treatment · Phase 3 · Prinses Maxima Centrum voor Kinderoncologie B.V.

  Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius

  Registry updated 2026-09-23

• NCT06652438

  Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

  Trial Treatment · Phase 3 · Stichting Hemato-Oncologie voor Volwassenen Nederland

  Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius

  Registry updated 2026-09-02

• NCT06788756

  L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

  Trial Treatment · Phase 2/3 · Moleculin Biotech, Inc.

  Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas

  Registry updated 2026-08-05

• NCT04953897

  Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

  Trial Treatment · Phase 1 · Taiho Oncology, Inc.

  BIO1, Vilnius

  Registry updated 2026-05-28

• NCT04953910

  Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

  Trial Treatment · Phase 1 · Taiho Oncology, Inc.

  BIO1, Vilnius

  Registry updated 2026-05-28

• NCT07075016

  Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy

  Trial Treatment · Phase 3 · Stichting Hemato-Oncologie voor Volwassenen Nederland

  LT-Vilnius-SANTA, Vilnius

  Registry updated 2025-08-19

• NCT06262438

  CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

  Trial Treatment · Phase 2 · Princess Maxima Center for Pediatric Oncology

  Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius

  Registry updated 2025-08-05

• NCT05477589

  Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML

  Trial Treatment · Phase 3 · Vastra Gotaland Region

  Vilnius University Hospital Santaros Klinikos Center for Pediatric Oncology and Hematology, Vilnius

  Registry updated 2024-12-19

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error